Benjamin Shepherd
Benjamin Shepherd
Send Message
Benjamin Shepherd
Stop FollowingBenjamin Shepherd
View as an RSS Feed
View Benjamin Shepherd's Articles BY TICKER:
- Japan's Coming Real Estate Revival
- A Fiscal Cliff Hedge For Slowing Discretionary Spending
- These Returns Aren't A Gamble
- 3 Weak-Dollar Dandies
- Groupo Aeroportuario del Pacifico: Fly Me Down Mexico Way
- Healthcare Reform: Winners And Losers
- My Favorite ETF For Gaining Exposure To High-Yield Emerging Market Debt
- Cresud: An Undervalued Play On Global Growth In Food Demand
- Third Time May Not Bring Charm For The Fed
- 3 Dividend-Paying Hedges For A Declining Dollar
- Finding Bargains In Transportation Stocks
- Sociedad Quimica Y Minera: Buy The Battery Craze
- Emerging Market Health Care: Prognosis Profitable
- Turkcell Iletisim Hizmetleri A.S: A Turkish Delight
- Economic Reforms In India Likely To Stick This Time
- Apple Dividends Fueling Distribution Growth For Select Sector SPDR
- Investors Not Appreciating Cost Savings Realized By Post-Merger LATAM Airlines Group
- Brazil's Wal-Mart Counterpart To Benefit From Rising Incomes
- Investing In The "Forgotten" Emerging Market: Mexico
- A Look At 2 Undervalued Small-Cap Healthcare Stocks
-
A 'Supreme' Lift For Wellpoint
- Finding Bargains In Asia
- Head To Head: ALPS Alerian MLP ETF Vs. JPMorgan Alerian MLP Index
- Minimize Volatility With These 2 SPDR Sector ETFs
- Sell-Off In Global Payments Following Hacker Incident Overdone
- Alerian MLP ETF: Short-Term Headwinds Don't Undermine Long-Term Growth Prospects
-
PIMCO Total Return: Bill Gross's Foray Into ETFs Living Up To The Hype
- ALPS Alerian MLP ETF: In The Right Sector At The Right Time
- An ETF For Latest Boom In Tech Stocks: Technology Select Sector SPDR
- Recessionary Opportunity
- KRE: An ETF To Capitalize On Growth In Regional Banks
- Biotech Gets Personal: Long On Qiagen And SPDR S&P Biotech
